Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MB

Michael Howard Block — 14 Patents

Astrazeneca Ab: 12 patents #60 of 1,971Top 4%
ICICI: 2 patents #677 of 2,189Top 35%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Michael Howard Block has been granted 14 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 1994 and the most recent in May 2011. Michael Howard Block ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Michael Howard Block in Gosport, MA, GB.

Patents per Year

Patents granted per year, 1994 to 2011Bar chart with a peak of 3 patents in 2005.peak 31994: 1 patents19941996: 1 patents19962002: 1 patents20022003: 1 patents20032004: 1 patents20042005: 3 patents20052008: 3 patents20082009: 2 patents20092011: 1 patents2011

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7951830 Compounds effecting glucokinase Scott Boyd, Peter William Rodney Caulkett, Rodney B. Hargreaves, Suzanne Saxon Bowker, Roger James +3 more 2011-05-31 $9,019,000
7524957 Compounds effecting glucokinase Scott Boyd, Peter William Rodney Caulkett, Rodney B. Hargreaves, Suzanne Saxon Bowker, Roger James +3 more 2009-04-28 $7,591,000
7498333 Enantiomers of selected fused heterocyclics and uses thereof Brian Aquila, Audrey Davies, Jayachandran Ezhuthachan, Sandra Ann Filla, Timothy Pontz +3 more 2009-03-03 $6,549,000
7408064 Carbazole derivatives and their use as NPY5 receptor antagonists Kevin Michael Foote, Wayne Brailsford 2008-08-05 $10,327,000
7390908 Compounds effecting glucokinase Scott Boyd, Peter William Rodney Caulkett, Rodney B. Hargreaves, Suzanne Saxon Bowker, Roger James +3 more 2008-06-24 $34,857,000
7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor Kevin Michael Foote 2008-02-19 $9,303,000
6967216 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor Craig Samuel Donald, David R. Brittain, Kevin Michael Foote 2005-11-22 $11,852,000
6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity Roger John Butlin, Thorsten Nowak, Jeremy Burrows 2005-11-01 $18,877,000
6878712 Amides as inhibitors for pyruvate dehydrogenase Roger John Butlin, Janet Elizabeth Pease, Thorsten Nowak, Jeremy Burrows, David Stephen Clarke 2005-04-12 $18,015,000
6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity Roger John Butlin, Janet Elizabeth Pease, Thorsten Nowak, Jeremy Burrows 2004-02-10 $12,055,000
6552225 Chemical compounds Roger John Butlin, Janet Elizabeth Pease, Thorsten Nowak, Jeremy Burrows 2003-04-22 $11,317,000
6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity Roger John Butlin, Thorsten Nowak, Jeremy Burrows 2002-12-24 $14,764,000
5500428 Furyl-substituted purines and adenosine antagonists Alison Harrison, Rodney B. Hargreaves 1996-03-19 $2,097,000
5300509 2-furyl-oxazolo[5,4-d]-pyrimidines Alison Harrison, Rodney B. Hargreaves 1994-04-05 $1,641,000